Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions.
Bioinformatics
Genetic diseases
Genetics
Infectious disease
Molecular diagnosis
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
22 04 2022
22 04 2022
Historique:
pubmed:
23
3
2022
medline:
26
4
2022
entrez:
22
3
2022
Statut:
epublish
Résumé
Severe viral infections of the skin can occur in patients with inborn errors of immunity (IEI). We report an all-in-one whole-transcriptome sequencing-based method by RNA-Seq on a single skin biopsy for concomitantly identifying the cutaneous virome and the underlying IEI. Skin biopsies were obtained from healthy and lesional skin from patients with cutaneous infections suspected to be of viral origin. RNA-Seq was utilized as the first-tier strategy for unbiased human genome-wide rare variant detection. Reads unaligned to the human genome were utilized for the exploration of 926 viruses in a viral genome catalog. In 9 families studied, the patients carried pathogenic variants in 6 human IEI genes, including IL2RG, WAS, CIB1, STK4, GATA2, and DOCK8. Gene expression profiling also confirmed pathogenicity of the human variants and permitted genome-wide homozygosity mapping, which assisted in identification of candidate genes in consanguineous families. This automated, online, all-in-one computational pipeline, called VirPy, enables simultaneous detection of the viral triggers and the human genetic variants underlying skin lesions in patients with suspected IEI and viral dermatosis.
Identifiants
pubmed: 35316210
pii: 156021
doi: 10.1172/jci.insight.156021
pmc: PMC9089792
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI143810
Pays : United States
Références
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Rev Microbiol. 2022 Feb;20(2):95-108
pubmed: 34522050
J Invest Dermatol. 2019 Jan;139(1):241-244
pubmed: 30036492
Science. 2003 Apr 11;300(5617):286-90
pubmed: 12690187
Annu Rev Pathol. 2021 Jan 24;16:23-50
pubmed: 32289233
Nat Rev Immunol. 2010 Jul;10(7):514-26
pubmed: 20577268
Clin Cancer Res. 2022 Mar 01;28(5):915-927
pubmed: 34911681
J Invest Dermatol. 2022 May;142(5):1265-1269
pubmed: 34843682
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Inflamm Regen. 2021 Mar 25;41(1):9
pubmed: 33766139
J Invest Dermatol. 2019 May;139(5):1195-1198
pubmed: 30503243
Bioinformatics. 2021 Jun 16;37(10):1465-1467
pubmed: 33017003
Cell. 2021 Jul 8;184(14):3812-3828.e30
pubmed: 34214472
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nucleic Acids Res. 2003 Jul 1;31(13):3568-71
pubmed: 12824367
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Invest Dermatol. 2020 Jun;140(6):1117-1126.e1
pubmed: 32446329
BMC Med Genomics. 2019 Jan 31;12(Suppl 1):19
pubmed: 30704462
Mol Oncol. 2019 Apr;13(4):829-839
pubmed: 30597724
Front Microbiol. 2018 Jun 12;9:1222
pubmed: 29946305
Med Clin North Am. 2021 Jul;105(4):783-797
pubmed: 34059250
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Clin Chem. 2021 Jun 1;67(6):876-888
pubmed: 33969388
J Clin Immunol. 2020 Jan;40(1):66-81
pubmed: 32048120
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Clin Infect Dis. 2019 May 17;68(11):1938-1941
pubmed: 30778533
Nat Methods. 2013 Jan;10(1):71-3
pubmed: 23160280